<DOC>
	<DOCNO>NCT02637050</DOCNO>
	<brief_summary>The aim registry assessment diagnosis treatment CTEPH ( Chronic Thromboembolic Pulmonary Hypertension ) EMEA ( Europe/Middle East/Africa ) country .</brief_summary>
	<brief_title>A Study Investigating Routine Practice Chronic Thromboembolic Pulmonary Hypertension Management EMEA Countries</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>Female male patient ≥ 18 year age , diagnose CTEPH regardless current treatment Availability sign informed consent WHO Pulmonary Hypertension clinical classification Group IV ( CTEPH ) : 1 . Right heart catheterization ( RHC ) result line follow haemodynamic level : Mean pulmonary arterial pressure ( PAP ) ≥ 25 mmHg rest Pulmonary arterial wedge pressure ( PAWP ) ≤ 15 mmHg 2 . Confirmation CTEPH diagnosis one follow recommended standard guideline : At least 1 ( segmental ) perfusion defect ( ) ventilation/perfusion ( V/Q ) scan Pulmonary artery obstruction see MDCT ( multidetector compute tomography ) angiography Pulmonary artery obstruction see conventional pulmonary cineangiography ( In case suspicion/diagnosis 'subacute ' Pulmonary Embolism : Patients treated anticoagulation least 3 month diagnosis CTEPH ) Patients underlie medical disorder anticipate life expectancy le 6 month Any medical condition , opinion investigator , could jeopardize safety patient his/her compliance study , otherwise make patient inappropriate study participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Type IV Pulmonary Hypertension</keyword>
	<keyword>Chronic Thromboembolic Pulmonary Hypertension</keyword>
	<keyword>CTEPH</keyword>
</DOC>